Photo Credit: ShutterstockWith the vaccine being available, Haute MD Experts share if it is safer to travel. Here’s what they had to say:

Dr. Vineet Sandhu | Concierge Medicine | New York

Yes, people who are fully vaccinated with an FDA-authorized vaccine can safely travel. Fully vaccinated people are those individuals who have waited until 2 weeks after the final dose of the vaccine. Precautions still apply when traveling such as wearing a mask over the nose and mouth, avoiding large crowds, and hand-washing often. Finally, self-monitor for symptoms and get a viral test 3-5 days after traveling. This applies to both domestic and international trips although it is safer to travel domestically at this moment because of increased exposure to variants during international travel.

Born in NYC, and raised in NJ, Dr. Sandhu has traveled around the country for undergraduate school, medical school, and residency. He completed his Internal Medicine residency at Indiana University and then joined a large multi-care specialty group where he rapidly experienced many cases in a short amount of time. Now with roughly 10 years of medical experience, he is able to treat conditions ranging from congestive heart failure, COVID-19, diabetes, anxiety, bronchitis, sinusitis, and the common cold. With Concierge MD NYC, Dr. Sandhu is able to spend time with his patients and provide a specific high-end plan. 

Dr. Bankole Johnson | Medical Sanctuary | Miami/Fort Lauderdale

The best advice remains only traveling if really needed. COVID-19 is still spreading at unacceptably high rates, and insufficient numbers of the population have been vaccinated.

Professor Dr. Bankole Johnson (2013 – 2019) served as The Dr. Irving J. Taylor Professor and Chair in the Department of Psychiatry, and Professor of Anatomy & Neurobiology, Medicine, Neurology, and Pharmacology at the University of Maryland School of Medicine. He directs all brain sciences across multiple departments at the School under the aegis of the Brain Science Research Consortium Unit, which grew in NIH funding from $21M-$35M from 2013-2018. Professor Johnson serves as the Director of the Clinical Neurobehavioral Center in Columbia. Professor Johnson is a licensed physician and board-certified psychiatrist. He is the Principal Investigator on National Institutes of Health (NIH)-funded research studies from basic science to molecular and clinical studies and has been funded continuously for over two decades.